DeutschNewstral
Article
bizjournals.com on 2019-05-20 12:37
After J&J sale, Cambridge investor sets sights on $175M raise for new medtech VC firm
Related news
UK DeepTech VC IQ Capital launches new $125M growth fund, closes third VC fund at $175MTechCrunch
Wilma J. Cambridge-Dempseybangordailynews.com- TThe sights of the Cambridge Square Markettheutcecho.com
Defender Leon Legge sets sights on Cambridge United targetsCambridge News- VC-backed French software firm chooses Cambridge for U.S. headquartersbizjournals.com
- With eye on blockchain, Cambridge VC firm raises $50M fundbizjournals.com
- Ex-Fidelity crypto experts launch VC fund in Cambridgebizjournals.com
- Cambridge VC firm aims to raise $100M fintech fundbizjournals.com
- This Cambridge VC firm is targeting a new $200M fundbizjournals.com
- Cambridge VC firm Flagship targets $500M for latest fundbizjournals.com
- Cambridge VC Flagship raises $824M for new life science investmentsbizjournals.com
- Cambridge biotech VC firm Clarus acquired by Blackstonebizjournals.com
- Cambridge fintech VC firm has raised $83M for second fundbizjournals.com
- Cambridge University sets its sights on £2 billion with biggest ever fundraising campaignCambridge News
- Cambridge students sets sights on Miss England crown ahead of Miss Cambridgeshire finalCambridge News
- Straight A* ‘miracle student’ who survived a brain tumour sets her sights on CambridgeCambridge News
Cambridge leaves ‘Footprint’ in Cambodia and sets sights on new chapter in Thailandcambodiadaily.com- Two familiar sights on the Cambridge biotech scene that will be gone in 2016bizjournals.com
- New Cambridge VC firm ElevateBio's first investment is a Houston biotechbizjournals.com
- Cambridge VC firm Link Ventures raises $100M for its second fundbizjournals.com